Notice of Correction of PAR-18-269 "Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional)"

Notice Number: NOT-MH-18-052

Key Dates
Release Date: September 24, 2018

Related Announcements
PAR-18-269

Issued by
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice to clarify the Application Types allowed in PAR-18-269, Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional).

Currently reads

Section II. Award Information 

Application Types Allowed

New (Phase I, Fast Track)
Renewal (Phase II* Direct Phase II not allowed)

The OER Glossary  and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.

Modified to read 

Section II. Award Information   

Application Types Allowed 

New (Phase I, Fast Track)
Renewal (Phase II* Direct Phase II not allowed)
Resubmission (all phases)
Revision

The OER Glossary and the SF424 (R&R) SBIR/STTR Application Guide provide details on these application types.

Section V. Application Review Information

Currently reads

Resubmission

Not Applicable

Revision

Not Applicable

Modified to read

Resubmissions

For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

Revisions

For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.

All other aspects of this FOA remain unchanged. 

Inquiries

Please direct all inquiries to:

Adam Haim, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-435-3593 
Email: haima@mail.nih.gov